Escola Paulista de Medicina
Postgraduate in Clinical Endocrinology
Carla Sanchez Bergamin1*, Elizabeth Pérez-Hurtado2, Luanda Oliveira3, Monica Gabbay1, Valdecira [ ... ]
Artigos Cientificos
Objective: As Selumetinib is a MEK1/2 inhibitor that has gained interest as an anti-tumor agent, [ ... ]
© 2013 - 2019 Universidade Federal de São Paulo - Unifesp
Rua Estado de Israel, 639 - Vila Clementino - São Paulo/SP - 04022-001 • 5089-9200 Ramal 2416